Found 6 matching trials
Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer
PHASE2This study is a prospective, single-center, open-label, umbrella-shaped pha...
Location
Cancer Hospital Affiliated to Fudan University
Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer
PHASE1The aim of this study is to identify the optimal dose for EP0062 as monothe...
Location
Yale School of Medicine
Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer
PHASE1The study is a Phase 1b/2, multi-center, open-label, dose escalation trial ...
Location
START Los Angeles
Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer
PHASE2The majority of patients (pts) with breast cancer have hormone receptor pos...
Status
Active Not Recruiting
Location
University of Miami
Phase I Study to Evaluate SIM0270 Alone or in Combination in ER+, HER2- Locally Advanced or Metastatic Breast Cancer
PHASE1This study is a multi-center, open-label, Phase 1 clinical study to evaluat...
Status
Active Not Recruiting
Location
Fudan University Shanghai Cancer Center
Elacestrant With Everolimus for the Treatment of Recurrent Advanced or Metastatic ER-Positive Endometrial Cancer
PHASE2This phase II trial tests how well elacestrant with everolimus works for th...
Location
UCLA / Jonsson Comprehensive Cancer Center